MedPath

Foscavir

FOSCAVIR INJECTION

Approved
Approval ID

a09299d5-9c55-4cef-aed0-3a6a45532289

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 2, 2023

Manufacturers
FDA

Clinigen Limited

DUNS: 211471076

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

foscarnet sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76310-024
Application NumberNDA020068
Product Classification
M
Marketing Category
C73594
G
Generic Name
foscarnet sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 19, 2020
FDA Product Classification

INGREDIENTS (3)

foscarnet sodiumActive
Quantity: 24 mg in 1 mL
Code: 964YS0OOG1
Classification: ACTIB
hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Foscavir - FDA Drug Approval Details